These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Secretory Phospholipase A Gergen AK; Jarrett MJ; Li A; White AM; Meng X; Fullerton DA; Weyant MJ J Surg Res; 2021 Mar; 259():562-568. PubMed ID: 33261858 [TBL] [Abstract][Full Text] [Related]
5. Activation of Akt is increased in the dysplasia-carcinoma sequence in Barrett's oesophagus and contributes to increased proliferation and inhibition of apoptosis: a histopathological and functional study. Beales IL; Ogunwobi O; Cameron E; El-Amin K; Mutungi G; Wilkinson M BMC Cancer; 2007 Jun; 7():97. PubMed ID: 17559672 [TBL] [Abstract][Full Text] [Related]
7. Expression of alpha-methylacyl coenzyme A racemase in the dysplasia carcinoma sequence associated with Barrett's esophagus. Scheil-Bertram S; Lorenz D; Ell C; Sheremet E; Fisseler-Eckhoff A Mod Pathol; 2008 Aug; 21(8):961-7. PubMed ID: 18500268 [TBL] [Abstract][Full Text] [Related]
8. Secretory Phospholipase A2 IIa Mediates Expression of Growth Factor Receptors in Esophageal Adenocarcinoma. Halpern AL; Kohtz PD; White AM; Houk AK; Rehring JF; Hanson L; McCarter MD; Joshi M; Meng X; Fullerton DA; Weyant MJ Dig Dis Sci; 2021 Mar; 66(3):784-795. PubMed ID: 32277371 [TBL] [Abstract][Full Text] [Related]
9. Expression profiles of cancer stem cell markers: CD133, CD44, Musashi-1 and EpCAM in the cardiac mucosa-Barrett's esophagus-early esophageal adenocarcinoma-advanced esophageal adenocarcinoma sequence. Mokrowiecka A; Veits L; Falkeis C; Musial J; Kordek R; Lochowski M; Kozak J; Wierzchniewska-Lawska A; Vieth M; Malecka-Panas E Pathol Res Pract; 2017 Mar; 213(3):205-209. PubMed ID: 28216140 [TBL] [Abstract][Full Text] [Related]
10. Alteration of glutathione S-transferase levels in Barrett's metaplasia compared to normal oesophageal epithelium. Cobbe SC; Scobie GC; Pohler E; Hayes JD; Kernohan NM; Dillon JF Eur J Gastroenterol Hepatol; 2003 Jan; 15(1):41-7. PubMed ID: 12544693 [TBL] [Abstract][Full Text] [Related]
11. Aurora kinase A in Barrett's carcinogenesis. Rugge M; Fassan M; Zaninotto G; Pizzi M; Giacomelli L; Battaglia G; Rizzetto C; Parente P; Ancona E Hum Pathol; 2010 Oct; 41(10):1380-6. PubMed ID: 20656315 [TBL] [Abstract][Full Text] [Related]
12. Telomerase, hTERT and splice variants in Barrett's oesophagus and oesophageal adenocarcinoma. Barclay JY; Morris A; Nwokolo CU Eur J Gastroenterol Hepatol; 2005 Feb; 17(2):221-7. PubMed ID: 15674101 [TBL] [Abstract][Full Text] [Related]
13. Miniprobe confocal laser microscopy for the detection of invisible neoplasia in patients with Barrett's oesophagus. Pohl H; Rösch T; Vieth M; Koch M; Becker V; Anders M; Khalifa AC; Meining A Gut; 2008 Dec; 57(12):1648-53. PubMed ID: 18755886 [TBL] [Abstract][Full Text] [Related]
14. Expression of c-erbB-2 oncogene product in Barrett's adenocarcinoma: pathological and prognostic correlations. Fléjou JF; Paraf F; Muzeau F; Fékété F; Hénin D; Jothy S; Potet F J Clin Pathol; 1994 Jan; 47(1):23-6. PubMed ID: 7907608 [TBL] [Abstract][Full Text] [Related]
15. Intestinal metaplasia in Barrett's oesophagus may be an epiphenomenon rather than a preneoplastic condition, and CDX2-positive cardiac-type epithelium is associated with minute Barrett's tumour. Watanabe G; Ajioka Y; Takeuchi M; Annenkov A; Kato T; Watanabe K; Tani Y; Ikegami K; Yokota Y; Fukuda M Histopathology; 2015 Jan; 66(2):201-14. PubMed ID: 25040564 [TBL] [Abstract][Full Text] [Related]
16. Reduced expression of αGlcNAc in Barrett's oesophagus adjacent to Barrett's adenocarcinoma--a possible biomarker to predict the malignant potential of Barrett's oesophagus. Iwaya Y; Hasebe O; Koide N; Kitahara K; Suga T; Shinji A; Muraki T; Yokosawa S; Yamada S; Arakura N; Tanaka E; Nakayama J Histopathology; 2014 Mar; 64(4):536-46. PubMed ID: 24117499 [TBL] [Abstract][Full Text] [Related]
17. Decrease in Le(x) expression in esophageal adenocarcinomas arising in Barrett's epithelium. Engel U; McCombs R; Stranahan P; Pettijohn D; Hage E Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):245-8. PubMed ID: 9107429 [TBL] [Abstract][Full Text] [Related]
18. High-grade dysplasia and superficial adenocarcinoma in Barrett's esophagus: histological mapping and expression of p53, p21 and Bcl-2 oncoproteins. Chatelain D; Fléjou JF Virchows Arch; 2003 Jan; 442(1):18-24. PubMed ID: 12536310 [TBL] [Abstract][Full Text] [Related]
19. Increased expression of the 5-lipoxygenase pathway and its cellular localization in Barrett's adenocarcinoma. Boger PC; Shutt JD; Neale JR; Wilson SJ; Bateman AC; Holloway JW; Patel P; Sampson AP Histopathology; 2012 Sep; 61(3):509-17. PubMed ID: 22690932 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of fatty acid synthase expression in oesophageal mucosa of patients with oesophagitis, Barrett's oesophagus and adenocarcinoma. Crispino P; Alò PL; Rivera M; Barillà D; Nardi F; Mariotti M; Giancarlo Z; Botti C; Pica R; Cassieri C; Unim H; Paoluzi P J Cancer Res Clin Oncol; 2009 Nov; 135(11):1533-41. PubMed ID: 19471962 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]